120 related articles for article (PubMed ID: 30025278)
21. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S; Follmann D; Nunez O; Young NS
JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia.
Killick SB; Mufti G; Cavenagh JD; Mijovic A; Peacock JL; Gordon-Smith EC; Bowen DT; Marsh JC
Br J Haematol; 2003 Feb; 120(4):679-84. PubMed ID: 12588356
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
Fenaux P; Giagounidis A; Selleslag D; Beyne-Rauzy O; Mittelman M; Muus P; Nimer SD; Hellström-Lindberg E; Powell BL; Guerci-Bresler A; Sekeres MA; Deeg HJ; Del Cañizo C; Greenberg PL; Shammo JM; Skikne B; Yu X; List AF
J Hematol Oncol; 2017 Jun; 10(1):131. PubMed ID: 28651604
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer G; Greil R; Linkesch W; Nösslinger T; Stauder R; Burgstaller S; Fiegl M; Fridrik M; Girschikofsky M; Keil F; Petzer A
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):e143-9. PubMed ID: 26422252
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes.
Hata T; Tsushima H; Baba M; Imaizumi Y; Taguchi J; Imanishi D; Nagai K; Tomonaga M; Miyazaki Y
Int J Hematol; 2013 Dec; 98(6):687-93. PubMed ID: 24254637
[TBL] [Abstract][Full Text] [Related]
27. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
28. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
Yoshimi A; van den Heuvel-Eibrink MM; Baumann I; Schwarz S; Simonitsch-Klupp I; de Paepe P; Campr V; Kerndrup GB; O'Sullivan M; Devito R; Leguit R; Hernandez M; Dworzak M; de Moerloose B; Stary J; Hasle H; Smith OP; Zecca M; Catala A; Schmugge M; Locatelli F; Führer M; Fischer A; Guderle A; Nöllke P; Strahm B; Niemeyer CM
Haematologica; 2014 Apr; 99(4):656-63. PubMed ID: 24162791
[TBL] [Abstract][Full Text] [Related]
29. Antithymocyte globulin for patients with myelodysplastic syndrome.
Molldrem JJ; Caples M; Mavroudis D; Plante M; Young NS; Barrett AJ
Br J Haematol; 1997 Dec; 99(3):699-705. PubMed ID: 9401087
[TBL] [Abstract][Full Text] [Related]
30. [Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes].
Wang J; Qin T; Xu Z; Zhang Y; Zhang H; Fang L; Pan L; Hu N; Qu S; Li B; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):942-6. PubMed ID: 26632468
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
32. Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Deeg HJ; Jiang PY; Holmberg LA; Scott B; Petersdorf EW; Appelbaum FR
Leuk Res; 2004 Nov; 28(11):1177-80. PubMed ID: 15380342
[TBL] [Abstract][Full Text] [Related]
33. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
[TBL] [Abstract][Full Text] [Related]
34. Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion.
Toma A; Kosmider O; Chevret S; Delaunay J; Stamatoullas A; Rose C; Beyne-Rauzy O; Banos A; Guerci-Bresler A; Wickenhauser S; Caillot D; Laribi K; De Renzis B; Bordessoule D; Gardin C; Slama B; Sanhes L; Gruson B; Cony-Makhoul P; Chouffi B; Salanoubat C; Benramdane R; Legros L; Wattel E; Tertian G; Bouabdallah K; Guilhot F; Taksin AL; Cheze S; Maloum K; Nimuboma S; Soussain C; Isnard F; Gyan E; Petit R; Lejeune J; Sardnal V; Renneville A; Preudhomme C; Fontenay M; Fenaux P; Dreyfus F
Leukemia; 2016 Apr; 30(4):897-905. PubMed ID: 26500139
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
[TBL] [Abstract][Full Text] [Related]
36. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
37. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
Aivado M; Rong A; Stadler M; Germing U; Giagounidis A; Strupp C; Novotny J; Josten KM; Kobbe G; Hildebrandt B; Gattermann N; Aul C; Haas R; Ganser A
Eur J Haematol; 2002 Apr; 68(4):210-6. PubMed ID: 12071936
[TBL] [Abstract][Full Text] [Related]
38. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
39. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
40. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
